Published in Blood Weekly, April 30th, 2009
"The approval is an important step for us as we expand our international footprint to deliver the industry leading Genesis DM telehealth monitor and LifeStream Telehealth Ecosystem to the Australian healthcare market," said Terry...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.